FDA Adverse Event Malfunction Summary report: N

PIPELINE FLEX W/SHIELD TECHNOLOGY

MDR report key: 24028069 · Received January 9, 2026

Report

Report Number
2029214-2026-00044
Event Type
Malfunction
Date Received
January 9, 2026
Date of Event
December 30, 2025
Report Date
March 23, 2026
Manufacturer
MICRO THERAPEUTICS, INC. DBA EV3
Product Code
OUT
UDI-DI
00763000255152
PMA / PMN Number
P100018
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

CONTINUATION OF D10: PRODUCT ID: FG15150-0615-1S (LOT: 231572698); PRODUCT ID: PED2-450-20 (D007538); PRODUCT ID: PED2-500-25 (D022998). MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

PRODUCT ANALYSIS: AS FOUND CONDITION: THE PIPELINE FLEX SHIELD EMBOLIZATION DEVICE WAS RETURNED FOR ANALYSIS WITHIN SHIPPING BOX; AND WITHIN A PLASTIC BIO-POUCH. DAMAGE LOCATION DETAILS: NO BENT OR KINK WAS FOUND WITH PUSHWIRE. THE DISTAL HYPOTUBE AND PTFE SHRINK TUBING WERE FOUND TO BE INTACT WITH NO SIGNS OF ELONGATION. THE DISTAL AND PROXIMAL DPS RESTRAINTS WERE FOUND TO BE INTACT. THE DPS SLEEVES WERE FOUND INTACT WITH NO SIGNS OF DAMAGE. NO DEFECTS WERE FOUND WITH THE TIP COIL, DISTAL MARKER, RE-SHEATHING MARKER, PADS OR WITH THE PROXIMAL BUMPER. THE BRAID WAS RETURNED ALREADY DETACHED FROM THE PUSHER; THEREFORE, THE PROXIMAL AND DISTAL ENDS COULD NOT BE IDENTIFIED. THE PIPELINE FLEX SHIELD BRAID WAS FOUND FULLY OPENED AND DAMAGED. NO OTHER ANOMALIES WERE OBSERVED. TESTING/ANALYSIS: N/A . CONCLUSION: BASED ON THE ANALYSIS FINDINGS, THE PIPELINE FLEX SHIELD WAS NOT CONFIRMED TO HAVE FAILURE TO OPEN AS THE PROXIMAL AS THE PIPELINE FLEX SHIELD BRAID WAS FOUND FULLY OPENED AND DAMAGED. HOWEVER, THE ROOT CAUSE OF DAMAGE COULD NOT BE DETERMINED. POSSIBLE CAUSES OF ¿FAILURE/INCOMPLETE OPEN¿ INCLUDE VESSEL TORTUOSITY, DAMAGED BRAID, AND DEPLOYMENT OF THE BRAID IN THE VESSEL BEND. THE PIPELINE WAS POSITIONED IN A BEND. IT WAS NOTED THE PATIENT'S VESSEL TORTUOSITY WAS SEVERE IT IS LIKELY THAT THE SEVERE VESSEL TORTUOSITY MAY HAVE CONTRIBUTED TO THE REPORTED ISSUES. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

ADDITIONAL INFORMATION WAS RECEIVED STATING THAT THE CAUSE OF THE EVENT WAS THOUGHT TO BE DUE TO THE TORTUOUS ANATOMY.

Description of Event or Problem · 0

MEDTRONIC RECEIVED A REPORT THAT THE THREE PIPELINES FAILED TO OPEN; 1 DISTALLY, 1 PROXIMALLY, AND ONE BOTH DISTALLY AND PROXIMALLY. THE PATIENT WAS UNDERGOING TREATMENT FOR A RUPTURED, SACCULAR ANEURYSM LOCATED IN THE LEFT OPHTHALMIC ICA. THE MAX DIAMETER WAS ~2.3MM, AND THE NECK DIAMETER WAS ~2.4MM. THE LANDING ZONE WAS ~4.3MM DISTAL AND ~4.6MM PROXIMAL. THE PATIENT'S VESSEL TORTUOSITY WAS SEVERE. DUAL ANTIPLATELET TREATMENT WAS ADMINISTERED AND THE PRU LEVEL WAS 230. THE ACCESS VESSEL WAS THE LEFT ICA, WHICH WAS ~4.7MM IN DIAMETER. IT WAS REPORTED THAT THE PARENT VESSEL DIAMETER WAS INITIALLY MEASURED AT APPROXIMATELY 4.6 MM IN THE WORKING PROJECTION. BASED ON THIS MEASUREMENT, A 4.5 × 25 FLOW DIVERTER WAS SELECTED. DURING DEPLOYMENT, THE DISTAL END FAILED TO ACHIEVE ADEQUATE WALL APPOSITION. RE-SHEATHING AND REDEPLOYMENT WERE ATTEMPTED; HOWEVER, DISTAL MALAPPOSITION PERSISTED. THE VESSEL WAS THEN RE-MEASURED IN AN ALTERNATE ANGIOGRAPHIC PROJECTION, WHERE THE DIAMETER APPEARED TO BE APPROXIMATELY 4.7 MM. BASED ON THIS REASSESSMENT, A 5 × 25 FLOW DIVERTER WAS SELECTED. DURING DEPLOYMENT, THIS DEVICE DEMONSTRATED SIMILAR BEHAVIOR, WITH PERSISTENT DISTAL MALAPPOSITION. AFTERWARDS, THE ATTEMPTED WITH A 5X20 FLOW DIVERTER, WHICH DID OPEN DISTALLY BUT FAILED TO OPEN PROXIMALLY. TO NOTE, THERE WERE TWO SHARP BENDS. FURTHER CORRECTIVE STRATEGIES WERE ATTEMPTED, INCLUDING: DEPLOYMENT IN A STRAIGHTER VESSEL SEGMENT AND ATTEMPTED OPENING IN THE MCA AND USING OF THE DRAG-AND-PULL TECHNIQUE. DESPITE THESE MANEUVERS, ADEQUATE DISTAL WALL APPOSITION COULD NOT BE ACHIEVED. THE PROCEDURE WAS ABANDONED. THE PATIENT DID NOT EXPERIENCE ANY INJURY OR COMPLICATIONS. THE DEVICES WERE PREPARED AND FLUSHED ACCORDING TO THE INSTRUCTIONS FOR USE (IFU). LESS THAN 50% HAD BEEN DEPLOYED AND THE SECOND PIPELINE WAS NOT POSITIONED IN A BEND WHEN IT FAILED TO OPEN. THE THIRD PIPELINE WAS POSITIONED IN A BEND, AND MORE THAN 50% HAD BEEN DEPLOYED WHEN IT FAILED TO OPEN. THE PIPELINES HAD B EEN RESHEATHED 2 OR LESS TIMES. IT WAS NOTED THAT THE SECOND PIPELINE ALSO FAILED TO OPEN PROXIMALLY. ANCILLARY DEVICES INCLUDE A NEURONMAX SHEATH, NEURON GUIDE CATHETER, TRAXCESS GUIDEWIRE, AND PHENOM 27 MICROCATHETER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
89055 PIPELINE FLEX W/SHIELD TECHNOLOGY INTRACRANIAL ANEURYSM FLOW DIVERTER OUT MICRO THERAPEUTICS, INC. DBA EV3 PED2-500-20 D047942 00763000255152

Patients

Seq Age Sex Outcome Treatment
1 41 YR Male SEE H11...